Studies investigating the possible involvement of adenosine in the antisecretory action of morphine

General Pharmacology

Volumn 28, Issue 5, 1997, Pages 709-713

  Hancock, D L ^a   Coupar, I M ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

opioid receptor; A(2b) adenosine receptor; antisecretory; morphine; NECA; rat intestine; vasoactive intestinal peptide (VIP)

Indexed keywords

8 CYCLOPENTYL 1,3 DIPROPYLXANTHINE; ADENOSINE; ADENOSINE 5' (N ETHYLCARBOXAMIDE); ADENOSINE RECEPTOR BLOCKING AGENT; ADENOSINE RECEPTOR STIMULATING AGENT; MORPHINE; NALOXONE; RESERPINE; VASOACTIVE INTESTINAL POLYPEPTIDE;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DRUG MECHANISM; DRUG RECEPTOR BINDING; FEMALE; FLUID TRANSPORT; INTESTINE SECRETION; JEJUNUM; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR AFFINITY; RECEPTOR DENSITY; STOMACH ACID SECRETION; SUBCUTANEOUS DRUG ADMINISTRATION;

ADENOSINE; ADENOSINE-5'-(N-ETHYLCARBOXAMIDE); ANIMALS; DECEREBRATE STATE; FEMALE; INTESTINAL MUCOSA; JEJUNUM; MALE; MORPHINE; NALOXONE; NARCOTIC ANTAGONISTS; NOREPINEPHRINE; RATS; RATS, WISTAR; RECEPTORS, PURINERGIC P1; RESERPINE; SYMPATHOLYTICS; VASOACTIVE INTESTINAL PEPTIDE; XANTHINES;

EID: 0030952173     PISSN: 03063623     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-3623(96)00358-8     Document Type: Article

References (35)

1. 6-(R-phenylisopropyl)-adenosine (PIA) and caffeine on nociception and morphine-induced analgesia, tolerance and dependence. Eur. J. Pharmac. 112, 171-179.
2. 1-selective adenosine antagonist 8-cyclopentyt-1,3-dipropylxanthine to rat brain membranes. Naunyn-Schmiedeberg's Arch. Pharmac. 335, 59-63.
3. 3H]-NECA in rat striatal membranes. Mol. Pharmac. 29, 331-346.
4. Clanachan A. S., Johns A. and Paton D. M. (1977) Presynaptic inhibitory actions of adenine nucleotides and adenosine on neurotransmission in the rat vas deferens. Neuroscience 2, 597-602.
5. Collier H. O. J., Francis D. L., Henderson G. and Schneider C. (1974) Quasi morphine-abstinence syndrome. Nature 249, 471-473.
6. 1-adenosine receptor antagonist. J. Pharm. Pharmac. 43, 138-139.
7. Coupar I. M. (1983) Characterization of the opioid receptor population mediating inhibition of VIP-induced secretion from the small intestine of the rat. Br. J. Pharmac. 80, 371-376.
8. Coupar I. M. (1985) Choice of anaesthetic for intestinal absorption and secretion experiments using rats. J. Pharmac. Meth. 13, 331-338.
9. Coupar I. M. (1986) Tetrodotoxin inhibits directly acting stimulants of intestinal fluid secretion. J. Pharm. Pharmac. 38, 553-555.
10. Coupar I. M. (1987) Mini Review: Opioid action on the intestine; the importance of the mucosa. Life Sci. 41, 917-925.
11. Coupar I. M. and Taylor D. A. (1987) Evidence for tryptaminergic and nor-adrenergic involvement in the antisecretory action of morphine in the rat jejunum. J. Pharm. Pharmac. 39, 363-369.
12. DeLander G. E., Mosberg H. I. and Porreca F. (1992) Involvement of adenosine in antinociception produced by spinal or supraspinal receptor-selective opioid agonists: dissociation from gastrointestinal effects in mice. J. Pharmac. Exp. Ther. 263, 1097-1104.
13. DeLuca A. and Coupar I. M. (1996) Insights into opioid action in the intestinal tract. Pharmac. Ther. 69, 103-115.
14. 1 and theophylline. J. Pharmac. Exp. Ther. 193, 884-891.
15. Hancock D. L. and Coupar I. M. (1995) Functional characterisation of the adenosine receptor mediating inhibition of intestinal secretion. Br. J. Pharmac. 114, 152-156.
16. Hayashi E., Mori M., Yamada S. and Kunitomo M. (1978) Effects of purine compounds on cholinergic nerves, specificity of adenosine and related compounds on acetylcholine release in electrically stimulated guinea pig ileum. Eur. J. Pharmac. 48, 297-307.
17. Hedqvist P. and Fredholm B. B. (1976) Effects of adenosine on adrenergic neurotransmission; prejunctional inhibition and postjunccional enhancement. Naunyn-Schmiedeberg's Arch. Pharmac. 293, 217-223.
18. Henderson G. and Hughes J. (1976) The effects of morphine on the release of noradrenaline from the mouse vas deferens. Br. J. Pharmac. 57, 551-557.
19. Ho I. K., Loh H. H. and Way E. L. (1973) Cyclic adenosine monophosphate antagonism of morphine analgesia. J. Pharmac. Exp. Ther. 185, 336-346.
20. Holck M. I. and Marks B. H. (1978) Purine nucleoside and nucleotide interactions on normal and subsensitive alpha adrenoreceptor responsiveness in guinea-pig vas deferens. J. Pharmac. Exp. Ther. 205, 104-117.
21. Lee M. K. and Coupar I. M. (1982) Evidence implicating a prostaglandin as the mediator of intestinal fluid secretion induced by pithing: inhibition by indomethacin, morphine and pentobarbitone. J. Pharm. Pharmac. 34, 450-452.
22. Nakaki T., Nakadate T., Yamamoto S. and Kato R. (1981) Alpha-2 adrenergic inhibition of intestinal secretion induced by prostaglandin E1, vasoactive intestinal peptide and dibutyryl cyclic AMP in rat jejunum. J. Pharmac. Exp. Ther. 107, 637-641.
23. 3H] yohimbine and failure to inhibit cyclic AMP accumulation. Mol. Pharmac. 23, 228-234.
24. Paton W. D. M. (1957) The action of morphine and related substance on contraction and on acetylcholine output of coaxially stimulated guinea-pig ileum. Br. J. Pharmac. 12, 119-127.
25. 1 receptors in rat smooth muscle preparations. Br. J. Pharmac. 113, 1249-1256.
26. Perkins M. N. and Stone T. W. (1980) Blockade of striatal neurone responses to morphine by aminophylline: Evidence for adenosine mediation of opiate action. Br. J. Pharmocol. 69, 131-137.
27. Phillis J. W., Jiang B. J., Chelak B. A. and Wu P. (1980) The effect of morphine on purine and acetylcholine release from rat cerebral cortex: Evidence for a purinergic component in morphine's action. Pharmac. Biochem. Behav. 13, 421-427.
28. Sattin A. and Rail T. W. (1970) The effect of adenosine and adenine nucleotides on the cyclic adenosine 3′,5′-phosphate content of guinea pig cerebral cortex slices. Mol. Pharmac. 6, 13-23.
29. Sawynok J. and Jhamandas K. H. (1976) Inhibition of acetylcholine release from cholinergic nerves by adenosine, adenine nucleotides and mo-phine: antagonism by theophylline. J. Pharmac. Exp. Ther. 197, 379-390.
30. Smith A. D. (1972) Subcellular localization of noradrenaline in sympathetic neurones. Pharmac. Rev. 24, 435-457.
31. Stone T. W. (1981) Theophylline does not affect morphine inhibition of the isolated vas deferens. Br. J. Pharmac. 73, 787-789.
32. Sweeney M. I., White T. D. and Swaynok J. (1988) 5-Hydroxytryptamine releases adenosine from primary afferent nerve terminals in the spinal cord. Brain Res. 462, 346-349.
33. 1 receptors in rats. Eur. J. Pharmac. 215, 301-304.
34. 3H]clonidine binding sites induced by adenosine receptor agonists in rat vas deferens in vitro. Eur. J. Pharmac. 86, 265-269.
35. Westfall D. P., Stitzel R. E. and Rowe J. N. (1978) The postjunctional effects and neural release of purine compounds in the guinea-pig vas deferens. Eur. J. Pharmac. 50, 27-38.